Inpatient Hepatology Consultation

References

1. • Karlsen T.H.
   • Sheron N.
   • Zelber-Sagi S.
   • et al.
   The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality.
   Lancet. 2022; 399: 61-116
   View in Article

   • Google Scholar
2. • D’Amico G.
   • Garcia-Tsao G.
   • Pagliaro L.
   Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.
   J Hepatol. 2006; 44: 217-231
   View in Article

   • Google Scholar
3. • Desai A.P.
   • Mohan P.
   • Nokes B.
   • et al.
   Increasing Economic Burden in Hospitalized Patients With Cirrhosis: Analysis of a National Database.
   Clin Transl Gastroenterol. 2019; 10: e00062
   View in Article

   • Google Scholar
4. • European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver
   EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis.
   J Hepatol. 2018; 69: 406-460
   View in Article

   • Google Scholar
5. • Volk M.L.
   • Tocco R.S.
   • Bazick J.
   • et al.
   Hospital readmissions among patients with decompensated cirrhosis.
   Am J Gastroenterol. 2012; 107: 247-252
   View in Article

   • Google Scholar
6. • Sanyal A.J.
   • Bosch J.
   • Blei A.
   • et al.
   Portal hypertension and its complications.
   Gastroenterology. 2008; 134: 1715-1728
   View in Article

   • Google Scholar
7. • Kovalak M.
   • Lake J.
   • Mattek N.
   • et al.
   Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database.
   Gastrointest Endosc. 2007; 65: 82-88
   View in Article

   • Google Scholar
8. • Garcia-Tsao G.
   • Bosch J.
   • Groszmann R.J.
   Portal hypertension and variceal bleeding–unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference.
   Hepatology. 2008; 47: 1764-1772
   View in Article

   • Google Scholar
9. • Garcia-Tsao G.
   • Bosch J.
   Management of varices and variceal hemorrhage in cirrhosis.
   N Engl J Med. 2010; 362: 823-832
   View in Article

   • Google Scholar
10. • de Franchis R.
    • Bosch J.
    • Garcia-Tsao G.
    • et al.
    Baveno VII Faculty. Baveno VII - Renewing consensus in portal hypertension.
    J Hepatol. 2022; 76: 959-974
    View in Article

    • Google Scholar
11. • Villanueva C.
    • Colomo A.
    • Bosch A.
    • et al.
    Transfusion strategies for acute upper gastrointestinal bleeding.
    N Engl J Med. 2013; 368: 11-21
    View in Article

    • Google Scholar
12. • García-Pagán J.C.
    • Gracia-Sancho J.
    • Bosch J.
    Functional aspects on the pathophysiology of portal hypertension in cirrhosis.
    J Hepatol. 2012; 57: 458-461
    View in Article

    • Google Scholar
13. • Garcia-Tsao G.
    • Abraldes J.G.
    • Berzigotti A.
    • et al.
    Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases.
    Hepatology. 2017; 65: 310-335
    View in Article

    • Google Scholar
14. • Bernard B.
    • Grangé J.D.
    • Khac E.N.
    • et al.
    Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis.
    Hepatology. 1999; 29: 1655-1661
    View in Article

    • Google Scholar
15. • Chavez-Tapia N.C.
    • Barrientos-Gutierrez T.
    • Tellez-Avila F.
    • et al.
    Meta-analysis: antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding - an updated Cochrane review.
    Aliment Pharmacol Ther. 2011; 34: 509-518
    View in Article

    • Google Scholar
16. • García-Pagán J.C.
    • Caca K.
    • Bureau C.
    • et al.
    Early use of TIPS in patients with cirrhosis and variceal bleeding.
    N Engl J Med. 2010; 362: 2370-2379
    View in Article

    • Google Scholar
17. • Ginés P.
    • Quintero E.
    • Arroyo V.
    • et al.
    Compensated cirrhosis: natural history and prognostic factors.
    Hepatology. 1987; 7: 122-128
    View in Article

    • Google Scholar
18. • Biggins S.W.
    • Angeli P.
    • Garcia-Tsao G.
    • et al.
    Diagnosis, Evaluation, and Management of Ascites, Spontaneous Bacterial Peritonitis and Hepatorenal Syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases.
    Hepatology. 2021; 74: 1014-1048
    View in Article

    • Google Scholar
19. • Runyon B.A.
    • Montano A.A.
    • Akriviadis E.A.
    • et al.
    The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites.
    Ann Intern Med. 1992; 117: 215-220
    View in Article

    • Google Scholar
20. • Tandon P.
    • Garcia-Tsao G.
    Bacterial infections, sepsis, and multiorgan failure in cirrhosis.
    Semin Liver Dis. 2008; 28: 26-42
    View in Article

    • Google Scholar
21. • Piano S.
    • Singh V.
    • Caraceni P.
    • et al.
    Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.
    Gastroenterology. 2019; 156 (e10): 1368-1380
    View in Article

    • Google Scholar
22. • Wong C.L.
    • Holroyd-Leduc J.
    • Thorpe K.E.
    • et al.
    Does this patient have bacterial peritonitis or portal hypertension? How do I perform a paracentesis and analyze the results?.
    JAMA. 2008; 299: 1166-1178
    View in Article

    • Google Scholar
23. • Kim J.J.
    • Tsukamoto M.M.
    • Mathur A.K.
    • et al.
    Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis.
    Am J Gastroenterol. 2014; 109: 1436-1442
    View in Article

    • Google Scholar
24. • Runyon B.A.
    • Canawati H.N.
    • Akriviadis E.A.
    Optimization of ascitic fluid culture technique.
    Gastroenterology. 1988; 95: 1351-1355
    View in Article

    • Google Scholar
25. • Gravito-Soares M.
    • Gravito-Soares E.
    • Lopes S.
    • et al.
    Spontaneous fungal peritonitis: a rare but severe complication of liver cirrhosis.
    Eur J Gastroenterol Hepatol. 2017; 29: 1010-1016
    View in Article

    • Google Scholar
26. • Angeli P.
    • Garcia-Tsao G.
    • Nadim M.K.
    • et al.
    News in pathophysiology, definition and classification of hepatorenal syndrome: A step beyond the International Club of Ascites (ICA) consensus document.
    J Hepatol. 2019; 71: 811-822
    View in Article

    • Google Scholar
27. • Bernardi M.
    • Angeli P.
    • Claria J.
    • et al.
    Albumin in decompensated cirrhosis: new concepts and perspectives.
    Gut. 2020; 69: 1127-1138
    View in Article

    • Google Scholar
28. • Sort P.
    • Navasa M.
    • Arroyo V.
    • et al.
    Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.
    N Engl J Med. 1999; 341: 403-409
    View in Article

    • Google Scholar
29. • Ginés P.
    • Rimola A.
    • Planas R.
    • et al.
    Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial.
    Hepatology. 1990; 12: 716-724
    View in Article

    • Google Scholar
30. • Saleh Z.M.
    • Solano Q.P.
    • Louissaint J.
    • et al.
    The incidence and outcome of postoperative hepatic encephalopathy in patients with cirrhosis.
    United European Gastroenterol J. 2021; 9: 672-680
    View in Article

    • Google Scholar
31. • Vilstrup H.
    • Amodio P.
    • Bajaj J.
    • et al.
    Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.
    Hepatology. 2014; 60: 715-735
    View in Article

    • Google Scholar
32. • Tapper E.B.
    • Aberasturi D.
    • Zhao Z.
    • et al.
    Outcomes after hepatic encephalopathy in population-based cohorts of patients with cirrhosis.
    Aliment Pharmacol Ther. 2020; 51: 1397-1405
    View in Article

    • Google Scholar
33. • Ridola L.
    • Riggio O.
    • Gioia S.
    • et al.
    Clinical management of type C hepatic encephalopathy.
    United European Gastroenterol J. 2020; 8: 536-543
    View in Article

    • Google Scholar
34. • Mendizabal M.
    • Silva M.O.
    Images in clinical medicine.
    Asterixis. N Engl J Med. 2010; 363: e14
    View in Article

    • Google Scholar
35. • European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver
    EASL clinical practice guidelines on the management of hepatic encephalopathy.
    J Hepatol. 2022; 77: 807-824
    View in Article

    • Google Scholar
36. • Rose C.F.
    • Amodio P.
    • Bajaj J.S.
    • et al.
    Hepatic encephalopathy: Novel insights into classification, pathophysiology and therapy.
    J Hepatol. 2020; 73: 1526-1547
    View in Article

    • Google Scholar